Adalimumab (HUMIRA (R)) monotherapy significantly improves health utility in patients with severe rheumatoid arthritis (RA)

ANNALS OF THE RHEUMATIC DISEASES(2005)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要